Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 03, 2024 3:04pm
52 Views
Post# 35809263

RE:RE:AEZS should liquidate

RE:RE:AEZS should liquidate
Tencents wrote: The Harvard Business Review states almost 90% of mergers fail
this is mainly due to culture differences/poor communications and integration difficulties 


Gilles has been with AEZS for five years. They know eachother. CZO is mainly using AEZS as a source of funding given AEZS's cash, cashcow diagnostic, and tax loss carryforwards. The funding is being used to fuel CZO's own growth. The diagnostic can even be sold and turned into a PGX plant. 

Without this source of funding CZO may be looking at a regular financing with a full warrant. According to Ronnie Miller the merger makes the most sense. The merger can be seen as two C$100 million market cap companies coming together to fuel CZO's growth.

<< Previous
Bullboard Posts
Next >>